数字乳腺X线摄影与数字乳腺断层摄影后致密乳腺超声筛查的检出率比较
该回顾性研究在两家三级乳腺影像中心和一家由同一批乳腺放射科医师执业的门诊机构中,比较了数字乳腺X线摄影(DM)后与数字乳腺断层摄影(DBT)后进行致密乳腺超声筛查的检出率。共纳入3183次筛查超声,DM后1434次(45.1%),DBT后1668次(52.4%)。超声额外癌症检出率在DM后为5/1434(每1000名筛查女性3.5例),在DBT后为5/1668(每1000名筛查女性3.0例),差异无统计学意义(p=0.9999)。
要点
- 致密乳腺超声筛查在DM后与DBT后的额外癌症检出率分别为每1000名女性3.5例和3.0例,无显著差异(p=0.9999)。
- DM后活检或囊肿抽吸的恶性比例为6/36(16.7%),DBT后为11/82(13.4%),无显著差异(p=0.8583)。
- 研究纳入3183次筛查超声,其中DM后1434次(45.1%),DBT后1668次(52.4%),81次(2.5%)无既往乳腺X线摄影可用。
核心结论
- 数字乳腺X线摄影后与数字乳腺断层摄影后进行致密乳腺超声筛查的额外癌症检出率无显著差异。
研究设计与样本
- 经机构审查委员会批准、符合HIPAA的回顾性研究,回顾性检索两家三级乳腺影像中心和一家由同一批乳腺放射科医师执业的门诊机构2014年10月1日至2016年9月30日的筛查超声检查,比较既往数字乳腺X线摄影与数字乳腺断层摄影后的筛查超声及病理结果。
诊断标准与关键数值
- 超声额外癌症检出率:数字乳腺X线摄影后为5/1434,即每1000名筛查女性3.5例;数字乳腺断层摄影后为5/1668,即每1000名筛查女性3.0例(p=0.9999)。
- 活检或囊肿抽吸恶性比例:数字乳腺X线摄影后为6/36(16.7%),数字乳腺断层摄影后为11/82(13.4%)(p=0.8583)。
- 推荐活检或囊肿抽吸的122例患者(均为BI-RADS 4类或BI-RADS 5类检查)中,118例(96.7%)有活检或囊肿抽吸结果。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE. The objective of this study was to compare the yield of dense breast ultrasound (US) screening after digital mammography (DM) versus after digital breast tomosyn-thesis (DBT). MATERIALS AND METHODS. For this institutional review board-approved, HIPAA-compliant study, we retrospectively searched databases at two tertiary breast imaging centers and an office practice staffed by the same fellowship-trained breast radiologists for screening US examinations from October 1, 2014, to September 30, 2016. Prior DM versus DBT and screening US and pathology results were recorded. Mammographically occult cancers detected with US and additional benign lesions requiring biopsy were calculated. Differences between DM and DBT were compared using the two-sample proportions z test. RESULTS. A total of 3183 screening breast US examinations were performed, 1434 (45.1%) after DM and 1668 (52.4%) after DBT. Of the 3183 examinations, 81 (2.5%) had no prior mammogram available. Of the 122 DM and DBT patients for whom biopsy or cyst aspiration was recommended (all BI-RADS assessment category 4 or BI-RADS assessment category 5 studies), 118 (96.7%) had biopsy or cyst aspiration results available. Of the 36 biopsies or aspirations after DM, 6 (16.7%) were malignant and 30 (83.3%) were benign; of the 82 biopsies or aspirations after DBT, 11 (13.4%) were malignant and 71 (86.6%) were benign (p = 0.8583). The additional cancer detection rate by US after DM was 5/1434 or 3.5 per 1000 women screened and after DBT was 5/1668 or 3.0 per 1000 women screened (p = 0.9999). CONCLUSION. No significant difference in additional cancer detection rate was found with screening US after DM versus after DBT.
引用
- Dibble EH, Singer TM, Jimoh N, et al. Dense Breast Ultrasound Screening After Digital Mammography Versus After Digital Breast Tomosynthesis. AJR Am J Roentgenol. 2019. PMID: 31553658. doi:10.2214/AJR.18.20748
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。